5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 5.09▲ | 5.08▲ | 5.08▲ | 5.05▲ | 4.96▲ |
MA10 | 5.08▲ | 5.08▲ | 5.08▲ | 4.92▲ | 5.17▼ |
MA20 | 5.06▲ | 5.04▲ | 5.01▲ | 4.85▲ | 6.21▼ |
MA50 | 4.93▲ | 4.93▲ | 4.87▲ | 5.32▼ | 6.09▼ |
MA100 | 5.01▲ | 5.18▼ | 5.42▼ | 6.27▼ | 4.02▲ |
MA200 | 5.70▼ | 6.35▼ | 6.33▼ | 6.55▼ | 4.27▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.001▲ | 0.002▲ | 0.009▲ | 0.084▲ | -0.202▼ |
RSI | 68.240▲ | 66.383▲ | 64.478▲ | 51.536▲ | 42.286▼ |
STOCH | 63.889 | 51.852 | 56.734 | 79.079 | 17.507▼ |
WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -18.519▲ | -86.200▼ |
CCI | 214.612▲ | 191.935▲ | 174.609▲ | 102.627▲ | -53.186 |
Tuesday, September 16, 2025 05:14 AM
ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Strategy” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. The small-cap ...
|
Tuesday, September 16, 2025 03:15 AM
Posters support Ohtuvayre® (ensifentrine) as a first-in-class selective dual inhibitor of PDE3 and PDE4 for a broad COPD population LONDON and RALEIGH, N.C., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Verona ...
|
Monday, September 15, 2025 06:38 AM
Tyr Pharma (NASDAQ:ATYR) saw its stock tumble 80% following the announcement that its Phase 3 EFZO-FIT trial of efzofitimod in pulmonary sarcoidosis did not meet the primary endpoint. The study’s main ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/09/25 | 5.0119 | 5.1568 | 4.91 | 5.09 | 23,107 |
15/09/25 | 5.01 | 5.19 | 5.01 | 5.19 | 2,666 |
12/09/25 | 4.96 | 5.15 | 4.96 | 5.00 | 14,145 |
11/09/25 | 4.95 | 5.0251 | 4.9402 | 4.99 | 5,030 |
10/09/25 | 4.85 | 5.00 | 4.75 | 5.00 | 5,173 |
09/09/25 | 4.72 | 4.81 | 4.72 | 4.77 | 7,214 |
08/09/25 | 4.81 | 4.83 | 4.7025 | 4.83 | 3,431 |
05/09/25 | 4.82 | 4.87 | 4.78 | 4.87 | 2,776 |
04/09/25 | 4.71 | 4.80 | 4.71 | 4.79 | 1,790 |
03/09/25 | 4.75 | 4.81 | 4.65 | 4.65 | 11,000 |
|
|
||||
|
|
||||
|
|